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THE CHEMOTHERAPY OF PROTOZOAN
AND BACTERIAL INFECTIONS
1

DR. WALTER A. JACOBS

T

The Rockefeller Institute for Medical Research

HE term Chemotherapy in its more restricted sense is
employed to designate that branch of investigation which
deals with the discovery of chemical agents which act specifically
on infectious diseases and with the study of their mode of
action. The introduction of this term we owe to Ehrlich and
the great progress which has been made in this field within
the comparatively shor; space of two decades is due largely
to the brilliant achievements and leadership of this worker. 1'he
subject is now so vast that in the short time which is allotted
to us we cannot do more than discuss certain phases of what
has been learned. Our treatment of the subject must naturally
fall into two divisions, that dealing with the chemotherapy of
bacterial infections and finally, that in which animal parasites
have been made the objective. We shall deal with the former
first, since efforts to· iniluence experimental bacterial infections
with chemical compounds antedate similar studies with . ani
nral parasites.
Not long after it became known that there are substances
which would kill micro-organisms in the test tube, attempts were
made to apply such germicides to disinfection within the organ
ism. All of these expilriments postulated a direct action of
the chemical upon the micro-organism ·within the host such as
occurs in di-sinfection outside of the body. Among the very first
investigations in this direction were tho e of Koch 1 who attempted
to sterilize animals which h:ad been infected with anthrax bacillus
by the use of bichloride of mercury.
Although he was able to· inject this substance into the blood
in such an amount as to achieve a concentration many times
that which was necessary to kill the micro-organisms in vitro, all
' Delivered December 8, 1.923.
67

68

HARVEY SOCIETY

the attempts proved fruitless. Koch attributed the discrepancy
between the in vitro and in vivo results to the fact that mercuric
chloride forms ·a chemical union with the serum proteins, as
evidenced by the formation of a precipitate and was therefore
rendered ineffective.
In later work, particularly that of von Behring, we see numer
ous other attempts to achieve internal disinfection. Occasionally
indications were obtained ,vith the use of certain inorganic sub
stances but such results proved of no practical value because
of their great uncertainty and irregularity and the great toxicity
for the animal shown by the amounts of chemical required.
Although occasional effo.rts in this direction continued, this
type of investigation came to be regarded as futile and almost
impossible of achievement. We can see in the words of von
Behring an expression of this gloomy outlook. After ten years
of persistent attempts he finally concludes: 2
'' It can be regarded almost as a law that the tissue cells
of man and animal are many, times more susceptible to the
poisonous effects of disinfectants than any bacteria known at
present. Therefore, before the antiseptic has a chance either
to kill or to inhibit the growth of the bacteria in the blood
or in the organs of the body, the infected animal itself will
be killed. The pessimism of him who declared that disinfection
in the living body is for all time impossible appears to be only
too justified. ' '
But with the more recent highly successful application of
synthetic drugs to the treatment of protozoan diseases and
because of the failure in so many instances of the more rational
immunological methods, interest again centered in the possi
bility of the therapeutic application of bactericidal agents. The
problem has proven extremely difficult to appro'aeh by any other
means. It has been particularly d�cult because of the lack
of an empirical background such as had placed t}le qualities
of arsenic, quinine and mercury at the disposal of the worker
with protozoan infections. It has seemed to some that the
only method short of the mere empirical testing of all sorts
of" substances in the experimental animal was to employ the
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bactericidal test at least '88 a means of initial orientation, even
though it appear the crudest makeshift.
The first extensive experiments in this direction were made
by Bechhold and Ehrlich, who found in the group of halo
genated phenols a number of substances which exhibited in vitro
a high order of inhibiting action on the growth, especially of
the diphtheria bacillus. At }he same time it w-as possible to
follow certain influences which chemical constitution seemed
to exert on antiseptic action, such as the exalting effect, up to
certain limit.a, of the multiplication of halogen groups or the
addition of methyl groups to the molecule. But what is more
important was the observation that none of these substances
would sterilize laboratory animals infected with the diphtheria
bacillus, "and this, in spite of the fact that the toxicity of some
of the substances was low enough to permit the achievement
of a concentration in the blood 100 times that required to kill
this bacillus in the t.est tube. A possible explanation for this
failure w.as again found in the greater affinity of these disin
fectants for the blood proteins than for the bacteria. Although
no visible precipitate was caused on mixing their solutions with
serum, as in the c'ase of mercuric chloride, their bactericidal
action in vitro was greatly redu.ced by the process. In this
work we find for the first time the expression '' partial spe- .
cificity "to designate a type of selective antiseptic action which
a chemical may display towards a particular micro-organism.
Compatibility with serum and partial specificity are factors
upon which the subsequent workers with antiseptics have come
to lay particular emphasis and their observations have fur
nished us with not a few examples of the latter. In the tendency
toward specificity was found a grain of hope, since it seemed
a step in the right direction-in the direction of the specificity
displayed by immunity principles. Marty
instances of partial
l
specificity .have been observed especialy among the organic
dyes. A number of these observations have been used as the
basis of methods for the differentiation of bacteria in culture,
such as that which employs gentian violet in media to restrain
the growth of Gram-positive strains, or the use of brilliant green
JI
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to separate the typhoid from the colon bacillus. A study of the
bactericidal properties of the quaternary salts of hexamethy
lenetetramine has brought out instances of substances which
displayed a decided preference for the streptococcus. In not
a few cases, substances were found which killed the streptococcus
in dilutions which were 20-30 times greater than those required
to sterilize suspensions of meningocooous and gonococcus. A
most unusual example of specificity has come to light in the case
of the toxicity of the alkaloid optochin for the pneumococcus,
but to this we shall return later. Quite recently Browning,
Cohen and Gulbransen/ have uncovered perhaps a still more
remarkable instance in the case of the cyanine dye, sensitol red.
'fhe lethal effect which it displays against staphylococcus is 2000
times that which it exhibits against the colon bacillus in peptone
water. I am, however, not aware of any experiments which have
been performed with this substance in infected animals.
In the quality of serum oompatibility we have presented to
us in its simplest form the idea that a substance must display
a greater affinity-for the micro-organism than for the tissues
l
of the infected ·animal in order to be germicidaly efficacious.
But few substances have been found which retain their full
activity in the presence of serum. A few favorable inst�nces
have been observed among the juaternary salts of hexamethy
lenetetra.mine which were prepared from certain chloracetyl
amino compounds." A number of these exhibit a bactericidal
effect in serum and protein solution which is very little less than
that found in salt solutions, but their application to internal -dis
infection was without result. Optochin maintains toward the
pneumococcus a high degree of bactericidal efficiency in serum.
'l'he low concentration of 1: 20,000 in serum and even that of
1 : 8000 in oxalated blood have proved sufficient to kill this micro
organism in 2 hours and in much higher dilutions it exhibits a
definite growth restraining influence.o- However, tJ:iis is con
siderably less than what is observed in ordinary salt solution,
since in the latter medium a dilution of 1 to 500,000 or more
is all that is required. Much more favorable relationships have
been observed in the case of acridine compounds. Browning
4,
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and his co-work,ers 7 have found that diaminoacridine and it.s
methochlorides, or proftavine and flavine respectively, actually
exert a more potent action on the staphylococcus and colon bacil
lus in serum than in ordinary saline. This very unique quality
and the unusually potent b�ctericidal properties of these sub
stances led to their application in the local treatment of wound
infections.
Still more difficult than to find substances which will resist
the diverting inflmmce of serum constituent.a is to find antiseptics
which will maintain a high bactericidal effect in blood. In
experiments in our laboratories, Doctor Felton 8 m·ade a mnn
ber of observations in regard to this point, and was able to
find but few instances of substances which retain a high order
of antiseptic poteney in this medium. Mention may be made
of malachite green and a few of its derivatives and especially
the flavines and certain dyes of the rosinduline group. The
observed values were, however, lower than those shown in ordi
nary saline.
There are still other properties which may be considered
among the desiderata for the ideal internal disinfectant. One
of these is speed of bactericidal action. It has been very diffi
cult indeed to find substances which act rapidly under the con
ditions which obtain in the circulation. In order to kill the
pneumococcus in 15 minutes, optochin must be used in a con
centration of 1 :1000 in whole blood. Even.flavine in the same
concentration fails to sterilize in one hour, although in two hours
it may act in a dilution of 1 to 32,000. Taken alone, speed of
action may not be essential, especially if a substance can be
maintained sufficiently long in the cire1,tlation to develop slowly
its action or to exercise merely a growth restraining or bac
teriostatic effect. But here again we must postulate other con
ditions fo order to obtain such a result. Repeated observations
with optochin in animals and in man have shown that it is pos
sible to render the blood antiseptic for pneumococcus but the
observatio�s of Moore and Chesney 9 have shown that this may
be complicated by the development of fastness. Browning and
Gulbransen 10 h·ave demonstrated that the blood· of rabbits may
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display a degree of inhibiting action for staphylococcus and
the colon bacillus for several hours after the administration of
diaminoacridine, but this alone was apparently inadequate.
In the control of certain infectious processes the difficult
requirements of proper distribution :and tissue penetrability of
the antiseptic must be taken into consideration. In a former
lecture before this Society, Lewis, in describing his experi
mental studies on the chemotherapy of infections produced by
the tubercle bacillus, has stressed the importance of combining
in a substance a degree of germicidal action with specific tissue
penetrating power.
Finally, there is another group of requirements which must
be discussed in connection with the in vivo operation of bac
tericidal subst.ances. Not only must a substance be of sufficiently
low general toxicity, b-ut it must prove comparatively harmless
to the general powers of resistance and to the normal protective
mechanism of the infected animal. In this connection we may
have to deal with quite an extensive and perhaps less tangible
group of factors which c:an be incorporated into systematic
study only with the greatest difficulty. It may be just at this
point that the real difficulty lies and we shall have occasion
to refer to this later.
In this connection, observations have been made to deter
mine the effect on phagocytosis which might be exhibited by
bactericidal substances. The e�eriments of Felton 8 have
recently shown that not a few highly bactericidal dyes and
cinchona derivatives markedly reduce the phagocytic index in
dilutions ht which they might exhibit a bactericidal effect in
blood. Exc.eptions in this regard may perhaps be the flavines,
which, according to Browning, are not appreciably injurious
in dilutions -above 1 :500.
But if we consider in retrospect all of the conditions which
may separate the observed in vitro properties of an antiseptic
from its successful operation in an infected animal, it is apparent
that we have presented a very difficult case for the idea that
the control of bacterial infections m:ay be approached from
the standpoint of internal disi�fectio�, This has certainly been
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very generally borne out in attempts to apply such substances
in actual infections. We shall later see that even in the more
successful application of compounds to the control of protozoan
infections, there have appeared repeated discrepancies between
the action of substances on the parasite in th� test tube and
in the animal. It would seem, therefore, that for the time at
]east, we are thrown back on the empirical testing of substances
in the infected animal as the only safe procedure.
The first striking instance of the successful application of
a chemical to the treatment of a bacterial infection in the labora
tory animal we owe to the observations of Morgenroth and his co
workers. Previous studies of Neufeld 11 and others had shown
a certain biological similarity between trypanosomes, spirilla
and the pneum-0coccus in the susceptibility of their 00.velopes
to the dissolving action of bile salts. While engaged in a study
of the effect of quinine derivatives in experimental trypanosome
infections in small animals, Morgenroth and Halberstadter 12
were able to demonstrate a certain curative effect of these sub
stanc.es. Then partly beoouse of the possible biological similarity
between the pneumococcus and the trypanosome and because
of certain clinical observations on the applicability of quinine
in the treatment of pneumonia, he was induced to make similar
studies in experimental infections with the pneumococcus.
Morgenroth and \ievy 18 found that a pneumococcus septi�emia
induced in mice was but little affected by injections of quinine.
On passing to hydroquinine, which differs from it by but two
hydrogen atoms, a more definite influence was to be seen in
delaying the death of the animals. An optimal effect, however,
µ-reatly exceeding that of the former was furnished by ethyl
hydrocupreine, or optochin, in which the methoxyl group of
hydroquinine has been changed to ethoxyl. It was found p_ossi1:!le to save a good percentage of the infected animals by repeated
injections particularly of a solution of the drug in oil. Unfor
tunately the clinme.l application of the drug has been limited
by its untoward toxic properties, especially the tendency to
produce amblyopia. Moore and Chesney,9 from extensive observa
tions on patients suffering from acute lobar pneumonia, have
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concluded that the use of optochin · in the treatment of this
condition cannot be recommended, since it is impossible to admin
ister a sufficient amount to produce an effective concentration
in the blood stream without exposing the patient to the danger
of toxic effects. During the use of the necessarily subeffective
doses the pneumooocci wiere observed even to become fast to
the drug.
It would appear that Morgenroth in his first experiments
was unaware of the potent germicidal action of this substance
on the pneumococcus, so that a knowledge of this property played
no part in its initial chemotherapeutic application. We owe to
Wright a the recognition of this quality as well as that of the
fact that optochin kills the pneumococcus in high dilution in
the presence of serum. The confirmation of these observations
led Morgenroth to attribute the curative action of optochin.
in the animal to its direct bactericidal effect and in his later
studies he used the test tube as a guide. This later work 10
developed the interesting influence which the chemical struc
ture of the cinchona alkaloids exhibited on their specific anti
septic action.
On passing from quinine,· through hydroquinine to optochin,
a sudden jump in the action upon the pneumococcus occurs
to fall again on passing higher up the series of alkyl compounds.
However, with the stage of the isoamyl ether a bactericidal effec
tiveness towards streptococcus and staphylococcus becomes
evident which is augmented on passing to the heptyl and isooctyl
compounds and then drops again. These observations while inter
esting in themselves had to do rather with ex�emal disinfection
and proved inapplicable to the treatment of systemic infections.
It would seem that the powerful bactericidal properties of
optochin lend support to the belief that its curative effect in
mice is a result of its diretc bactericidal action. But certain
observations of Neufeld and Engwer,1 6 and later by Moore,1 7
have suggested the interposition of the host in the process.
Moore found that a single small dose of optochin in oil which
in itself was quite ineffective in the treatment of an experimental
pneumococcus septicemia in the mouse, when combined in the
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treatment with an amount of homologous anti-pneumococcus
serum which was also far under the effective dose was capable
of increasing the threshold value of this serum at least fifty
times. 'l'his result indicates that the combined action of the
two therapeutic agents was many times that of a simple summa
tion of their protective effects. Whether a similar synergism
or rather fortification occurs between the drug and certain unde
termined protective factors when the drug is used a,lone in a
so-called curative dose has not been definitely ascertained, but
Moore's observations would seem to weaken somewhat the view
that the bactericidal effect is the only factor-.
Taking all that we have considered with reference to opto
chin and its near relatives, as well as the ancient reputation
which quinine has always had, we cannot escape the enticing
suggestion that perhaps there is something inherent in the mole
:cule of these alkaloids which, like the elements arsenic and
mercury, has conferred upon them certain 1>otentialities as
specific etiological remedies and that this property might be
turned to wider usefulness if we could only find the way.
A number of years ago we turned our attention to this prob
lem in the laboratories of the Rockefeller Institute at the sug
gestion of Doctor Flexner and also of Doctor Cole who was par
ticularly interested in the possibility of finding new therapeutic
agents for the treatment of infections produced by the pneumo
coccus. In this work Doctor Heidelberger and I were extremely
fortunate in the enjoyment of the skilful biological cooperation of
Doctor W ollstein and later of Doctor Felton.
The first problem was purely chemical. We have already
seen what a pronounced change in biological properties has
followed but slight chemical alterations in the quinine mole
cule. Wonld it be possible to find other means of altering the
cinchona molecule in a systematic manner, but in a way to
maintain its general integrity, and perhaps permit us to follow
the influence of chemical modification on biological action f The
naturally occurring members of the group, as we have seen, had
been thoroughly studied and also their hydro-derivatives and
the homologous ethers of hydroquinine as well. A successful solu-
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tion of the chemic.al problem was found by making use of the
fact that these alkaloids as tertiary bases react with alk:ylhalides
to form quaternary salts. 18 In one direction in particular-by
the use of chloroacetylamino compounds as alkylhalides it was
possible to develop if necessary a practically unlimited number
of new derivatives, and, in a way, to leave the original alkaloid
molecule intact. Many substances were prepared into which a
thorough selection of the usual organic groups had been intro
duced. Then again a similar opportunity was offered in the
preparation of a series of hydroxyazo dyes from hydrocupreine,1 9
the phenolic compound obtained by demethylating hydroquinine.
By coupling hydrocupreine with the diazonium salt of any aro
matic amino compound it was possible to make a logical series
of substances in which any chemical change could be featured
at will. Still other series, 20 of a similar character were prepared,
so that in ·a way it might be said that the opportunity of test
ing the influence of chemical changes on the action of these
alkaloids had been fairly completely presented. While realizing
from all that was said before that the measure of bactericidal
power was of doubtful importance, nevertheless, such studies
were made because of their possible statistical value and since
no other criterion short of the animal test was available. Within
the groups of quaternary salts and a.zo dyes numerous instances
of marked bactericidal power for the pneumococcus were noted
and in several cases were found to equal even that of optochin.
However, in the majority of instances, this activity was found
to be greatly diminished in the presence of serum. I shall not
burden you with an extensive account of these observations, but
shall rather summarize the results obtained in the use of these
substances in the experimental pneumococcus infection. Such
tests made on substances, irrespective of bactericidal potency,
showed a few which seemed to exp.ibit a small measure of thera
peutic effect. The quaternary salts of hydroquinine with chlora
cetyl-p-'aminophenol and chloracetyl-p-anisidine, in particular,
if given not too long after inoculation of the mice or if not
in too large amounts, often, though irregularly, ea.red the ani
mals. An interesting and not infrequent observation which
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waa made with these and similar substances was the effect of
doses above a certain threshold, even though much under the
lethal dose. In such cases, instead of the apparent cure observed
with smaller doses, an actual acceleration of the disease was
noted. An explanation of this curious paradox is perhaps not
difficult to find, and may lie in the possibility that amounts of
drug which are not frankly toxic may be sufficient to injure
the animal's n·atural powers of resistance in such a way as to
make it more susceptible to the infection.
In this connection, we have made also a survtiy of the various
groups of organic dyes in regard to their curative effect on
pneu.mococcus infections in laboratory animals, but with similar
unpromising results. Even flavine with its high bactericidal
power in blood and serum for the pneu.mococcus gave but the
slightest indication of influencing the infection. Observations
made with quite a variety of other classes of substances were of
a similar negative character.
To sum up-while the experience of workers has brought
to light not a few groups of bactericidal compounds, very few
individual substances have displayed even a trace of specific
therapeutic activity. These few substances have proved to 'be
unique within the group to which they belonged, since closely
related compounds, or those differing from the active substances
i
insignificant chemical modifications have proved
by relatvely
to be quite useless. I shall not keep you longer with this portion
of the story except a word perhaps as to the general outlook for
the chemotherapy of bacterial infections. At present the data
available seem quite barren of suggestion. But I do not wish to
imitate here quite the gloomy view which w&i quoted at the begin
ning of this paper. The mere instance of optochin and of the
therapeutic value of chaulmoogra oil and the more recently used
esters of chaulmoogric and hydnocarpic acids obtained from this
oil in the treatment of leprosy are indications that the control
of bacterial infections by drugs is by no means impossible of
achievement. The real difficulty lies in the necessarily oppor
tunistic experimental method and the lack of a rational scientific
means of approach. , The problem is essentially a search for a
0
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substance of unknown nature but which must yet perform a ser
vice by a mechanism of which we are equally uncertain. It may
be possible to inquire successfully into what biological proper
ties such a substance must possess, or under what biological con
ditions it will have to �perate; but such information will not
point to the substance itself. In the case of bacterial inf!)ctions,
experience has presented us with too few points of contact be
tween our knowledge of chemical structure and whatever biologi
cal properties may be required in the exhibition of a therapeutic
effect to present a rational basis for the search for curative
substances. Perhaps the real solution of the problem may be
ultimately found by gaining an insight into the chemical nature
and mode of operation of the substances which are normally
elaborated by the organism i:n its fight against infection.
If we turn now to the appli�ation of chemical agents to the
tre·atment of protozoan diseases, we are confronted by a far
more encouraging state of affairs. We have already alluded
to the traditional virtue of quinine and mercury and that these
were purely empiri®-1 acquisitions. However, with the recogni
tion of the etiological factors of the diseases which these sub
stances influenced, the role which they occupied as real curative
agents was likewise recognized. During the past twenty years
considerably more has been added to our chemical equipment
in the treatment of this group of , diseases as a result of the
applic:ation of laboratory methods of both chemistry and biology.
In the present paper I can, however, touch upon only certain
phases of this development. The ·appearance in 1902 of the
classical experiments of Laveran and Mesnil, 21 was the beginning.
By the use of sodium arsenite these workers succeeded in tem
porarily clearing the blood of mice infected with the parasite
responsible for the disease of cattle called " Nagana." Then
there followed within a few years· a succession of observations
· in which substances belonging to a number of different groups
were found to possess a similar efficacy in experimental infec
tions produced by the same or similar animal parasites. These
substances fall naturally into sever·al groups which it will serve
our. purpose best to treat separately. Soon after the observations
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of Laveran and Mesnil, Ehrlich and Shiga, 22 demonstrated that
mice infected with trypanosoma equinum could be permanently
cured by a single injection of trypan red, a tetrazo dye prepared
by coupling tetrazotized benzidinesulfonic acid with a naphthyl
aminedisulfonic acid. This is noteworthy as the first instance
of the cure of an experimental trypanosome infection with a
single dose of a synthetic chemical. However, the value of the
substance itself seems to have been limit.e!l, since it failed to
exert a similar therapeutic effect in other animals or with other
types of trypanosomes.
We meet here for the first time a peculiar paradox which
was destined to appear repeatedly in later work. Although
trypan red proved to be active in vivo, it was inactive in the
test tube. At the time, these workers noted the staining of
the tissues of the animal by the dye after injection. They
consi_dered that its action was possibly due to the persistent
effect of small amounts of the drug or of some active alteration
product of it upon the parasites. The production of an activ:e
immunity in the animal by the rapid destruction of the parasites
by the drug wa8 considered also as a contributing factor. Obser
vations of a similar character with other dyes became the basis
for much subsequent discussion and inquiry as to the mechanism
involved in the successful removal of trypanosome infections
by such substances. In these discussions, which I cannot present
at length, attempts were made to explain this paradoxical action
also by the assumption of a direct injury produced by the dye
on the trypanosome of a character which did not affect their
motility but prevented their multiplication. The suggestion
that a chemical alteration of these substances in the body to a
more active form, while not so obviously applicable to this
class of substances, has been more successfully applied, as we
shall see, in explaining the action of arsenic compounds. Subse
quently, Nicolle and Mesnil, 23 found, from the study of a large
number of similar substances, a benzidine dye trypan blue which
proved still more efficacious in that it cured mice infected with
the more resistant trypanosomes of Nagana and Surra. Dyes
of all kinds were then investigated and, in succession, members
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of the triphenylmethane group and a number of orthoquinoid
dyes such as the pyronines, oxazines, thiazines and acridines
were successfully brought into the field of investigation. But
the practical application of the dyes, it would seem, has been
on the whole rather restricted. The discovery of the therapeutic
properties of the individual members of the different groups
appears to have been for the most part the outcome of a rather
opportunistic selection of substances. There have been attempts
to correlate the therapeutic properties of some of them to their
chemical constitution and to their selective staining property
for the parasite. But, on the surface at least, it would seem
that but few facts have emerged which could be applied to a
systematic attempt at their further chemical development, or
in explanation of whatever degree of therapeutic value they
may have shown.
An exception to this, perhaps, is the rather striking property
which was found by Ehrlich and his associates to accompany
t'he presence of the orthoquinoid structure of certain dyes. These
dyes quickly produced tolerant or fast strains of trypanosomes
which were also quite fast to arsenic. Paraquinoid dyes did
not show this effect. Again Nicolle and Mesnil,28 in a thorough
survey of the tetrazobenzidine dye group concluded that in
order to develop therapeutic qualities the coupler used must
be a naphthalene derivative containing at least one amino group
and two sulfonic acid groups. You will see from the chart that
this condition is satisfied by both trypan red and trypan blue.
And it is possible that this may have been made the starting
point for the preparation of a substance known as Bayer-205,
which has recently c:ome to offer considerable promise. The exact
nature of this substance has been carefully withheld but there
is a. suspicion that it belongs to a group of compounds which the
Bayer Company patented some time ago.H I have on the chart
formulm which suggest the possible relationship of this substance
to tryp·an red and trypan blue.
Preliminary observations of Handel and Joetten 23 and Mayer
and Zeiss, 28 have shown that this substance possesses remarkable
curative properties in experimental trypanosomiasis. In small

,
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doses which were often far below the toxic dose for the particular
animal, the drug was found to cure the ordinary laboratory
animals which had been infected with different strains of try
panosomes. Here again we find the curiowi circumstances that
the substance itself displayed no marked action on the trypano
somes in vitro and microscopic studies seemed to suggest that
the drug may act by preventing multiplication of the parasites.
Later, therapeutic experiments in dourine in horses pointed
to its usefulness as a prophylactic and curative agent but more
important was its application to hum.an trypanosomiasis. We
shall return to a discussion of this in another connection. Al
though we can only infer the probable nature of this remedy,
it would seem that an advance has been made by applying chemi
cal knowledge to the problem of varying a group of substances
which had already given indications of therapeutic values. Thus,
the dyes from which this substance has emerged have come to
share again, for the time at least, a prominence which was taken
from them very early in chemotherapeutic studies by the advance
in the application of arsenic compounds.
If we turn now to the arsenic group we find that the organic
arsenicals have proved a most profitable direction for the experi
mental studies which led to the finding of synthetic etiological
remedies. This is �ttributable in part to the fact that we are
dealing with substances in which the therapeutic quality is appar
ently inherent in the arsenic itself irrespective of the actual
form or by what mechanism its action may come into play. This
has made chemical reasoning simpler · in attempting to refer
biological action to chemfo:al constitution, for it is far more diffi
cult to interpret what should be the point of reference when a
large organic molecule is consi�ered with regard to any inherent
biological activity.
The impetus to investigation in this direction c:ame with the
report of Thomas,27 that a proprietary arsenic preparation called
atoxyl displayed a definite therapeutic effect in animals infected
with different strains of trypanosomes. The rapid confirma· tion
of this observa.t.ion soon led to its employment in African sleepG
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ing sickness :and it has proved helpiul in the treatment of the
early stages of this disease.
But a step of the most far-reaching importance was Ehrlich's
brilliant recognition of _ the true nature of atoxyl as the sodium
salt of p-aminophenylarsonic acid or arsanilic acid. 28 In analogy
with sulfanilic acid, it is formed by the fusion of aniline with
arsenic acid. In its essentials, the chemistry of organic arsenic
compounds had been pretty thoroughly studied by Michaelis and
his co-workers, but the methods at the disposal of these chemists
were, in a sense, limited. The discovery that arsenic could be
introduced into the molecule by direct arsenation opened to
Ehrlich and his associates a means for a most thorough develop
ment of the chemistry of this group of substances. The immediate
suggestion which the structure of p-aminophenylarsonic acid
presented was detoxification by acetylation of the amino group.
But the resulting product arsacetin, though possessed of a degree
of therapeutic power, was soon discarded because in i,ts c.linical
application, like· atoxyl, it not infrequently produced blindness
and other toxic manifestations. Here again the peculiar paradox
apI.iears that the pentavalent compounds are without appreciable
action on the trypanosomes in vitro. But Ehrlich's 29 fertile
imagination soon found a possible solution for this discrepancy.
l
' 'he fact was noted that individual animals treated with certain
pentavalent compounds would show a varying tolerance for
the drug and those which exhibited the lower tolerance could
be cured by smaller doses. This observation was coupled with
the well known ability of the tissues to exhibi� a reducing action
and with the fact that certain trivalent forms of arsenic are
far more toxic than the pentavalent forms. Ehrlich concluded
that the pentavalent arsenicals are reduced by the tissues and
unfold their activity in the trivalent form. This view was sup
ported by the direct comparison of the relative toxicities of the
three stages of oxidation of arsanilic acid, p-aminophenylar
sinoxide is 75 times more toxic for the mouse than arsanilic
acid, while the arseno compound is 30 times more toxic., Similar
toxicity relationships have been repeatedly observed.
But more important still is the contrast in the trypanocidal
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effect of the oxide and the arsonic acid in vitro. In a dilution of
1 :100,000 the !ormer kills the microorganisms immediately,
whereas atoxyl fails to act even in a 5 per cent. solution. In
some cases the arseno-�ompounds have shown a similar potent
action in the test tube but this has not always appeared. Men
tion may be made of observations of the failure of salvarsan to
act directly upon the relapsing fever organism so or on the
treponema pallidum in the test tube although the organisms
thus treated were observed to lose appreciably in virulence as
shown by subsequent injection into animal... Ehrlich and
Roehl 81 placed particular emphasis on the oxide stage which
may be formed either by reduction of the pentavalent compound
or by oxidation of the arseno-derivative as the form in which
the biological manifestations eventually appear. It is perhaps
important to mention this point, since recent statements have
appeared which seem to overlook this fact.;
The conception of the biological potency of trivalent arsenic
was at once applied to further synthetic attempts to· find new
curative ,agents in the arsenic group. The great toxicity of
the arsenoxides, however, and the possibilities which the arseno
r..ompounds came to afford was the reason for the main interest
which seemed to attach to the latter group. This work, as you
all know, culminated in the brilliant discovery of the value of
salvarsan and its derivatives in the treatment of certain spiro
chrete diseases.
In his theoretical considerations to explain the action of
chemotherapeutic agents, Ehrlich assumed a direct action of
the substance or its alteration product on the parasites. He
conceived this action as being brought about by the avidity of
certain groups or chemoceptors in the cell of the parasite for
certain groups contained in the che:miic:al. By assuming these
discrete affinities within the cell the attempt :was made to give
more visible expression to certain phenomena which were ob
served in the reaction of microorganisms to chemicals containing
certain groups in the molecule. But, on the whole, workers no
longer agree that such precise definition can be given to the
relationship between chemical constitution and therapeutic action.
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The efficacy of salvarsan was attributed in part to its orth
aminophenol group which was supposed to direct the drug at
the parasite in a way to permit the lethal action of the arsenic
to develop. The analogy was drawn with trypan blue which
likewise possesses an amino and hydroxyl group in positions
ortho to one another. But there are many cases where such
analogies do not hold. It is said, for instance, that the isomers
of salvarsan containing this configuration are all much less
active than salvarsan itself. Again particular stress has been
laid on the dystherapeutic effect of the methyl group but num
erous instances have arisen in which substances containing the
methyl group have actually exceeded in effectiveness the unmethy
lated com.pound. In this respect, trypaflavine is more efficacious
as a trypanocide than the unmethylated proflavine. Quinine,
which is methyloxycinchonidine is more efficacious in malaria than
cinchonidine or the phenol, cupreine. The sulfuric group is
still another well ·known example. In ma.ny combinations it
may destroy therapeutic efficiency. Morphine or quinine when
oonverted into the sulfuric esters, although again easily recover
able by saponification, are physiologically practically inert. On
the other hand, several sulfuric acid radicals are contained in
· the molecule of trypan red, trypan blue and probably Bayer-205.
The conclusion is forced, therefore, that we may attribute only
the bare possibility of certain effects to certain groups in the
molecule and in any event, the molecule as a whole certainly
must be considered.
But the striking changes in biologic:al properties that often
follow very minute changes in structure and the occasional
appearance of regularity of biological response to such cha:nges
have always been a fascination and a source of tem'ptation to
the worker to try to utilize such general tendencies in the synthe
sis of drugs. Several years ago, a group of us at the Rockefeller
Institute, Doctors Brown and Pearce and Heidelberger and
myself were tempted to take up a phase of this question. In
this work the attempt was made to obtain some information
from a systematic biological study of the toxic and therapeutic
properties of certain typ� of arsenic comppunds which might
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be applied to the finding of new remedies. 'l'his work which
at first embraced a study of the treatment of experimental try
panosomiasis was later extended to include that of the experi
mental infections produced by the relapsing lever organism and
experimental syphilis in the rabbit.
We have already described the emphasis which has been
placed on trivalent aisenicals. Since the biological activity was
an exhibition of a property of some form of trivalent arsenic, it
was undoubtedly a logical step, if considered alone, to use this
group of compounds directly. But we may regard this question
n
angle. There seems fair evidence at hand that the
from aother
greater tolerance for pentavalent arsenioals as a group is not
alone a function of their greater biological inertness as com
pared with the trivalent-compounds but also to the speed with
which the greater portion is excreted before the reducing action
of the tissues c:an manifest itself. This is but a manifestation
of the fact that the arsonic acids which form neutral salts
possess a relatively greater portability in the blood stream and
body :fluids than the trivalent forms as well as a greater pene
trability and may readily and quickly diffuse through the tissues.
The arsenoxides possess this to a much less degree and because
of their degree of unsaturation are chemically very reactive
and while perhaps initially portable, readily become bound by
and denaturize such functional or tissue elements as may be deter
mined by the general character of their molecule before the same
degree of distribution can be achieved. This rapid fixation finds
expression in the .rapid exhibition of potent toxic manifestations.
The arseno compounds as a group possess double the molecular
weight and, although perhaps also quite reactive, are the least
readily transported ·and the least diffusible of all. Where there
is no special acid salt forming group, substances of this class
may be held in solution for a short time only, aided perhaps
by the protective serum colloids, but may be readily deposited
as such along the route before complete distribution is possible
and then more slowly unfold their toxic effects through oxida
tion to the oxides. • If we were dealing with an. infection which
is confined to the blood stream alone it would seem, therefore,
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admissible to place reliance upon the direct quick action of the
trivalent compounds and the simple formula of the ratio of
parasitotropic to organotropic properties of a substance. But
when the more usual ti�ue infection is· to be influenced the
question of distribution and diffusibility becomes a very import
ant factor to consider. It is quite conceivable that certain advan
tages in this regard may result by the use of the pentavalent
form which may compensate for what it may seem to lose in
immediate direct parasiticidal properties. By more complete
distribution and tissue penetration it might be possible to reach
localities which m:ay harbor such residues of an infection as
may again become generally active. In such localities the reduc
ing action of the tissues may supply a small but sufficient amount
of therapeutically active material.
In spite of Ehrlich's somewhat orthodox adherence to the
trivalent idea we can see evidence of his occ:asional return to
the pentavalent compounds. In his Schlussbetrachtungen, 80 the
possibility is pointed out of the applicability of hydroxyamino
phenylarsonic acid, the pentavalent stage of salvarsan, for local
therapy where the arseno compound circulating in the blood
cannot reach the affected tissues in sufficient amount, as, for
instance, in local eye involvement. Hata 's experiments showed
severai pentavalent compounds to exhibit a good ratio of cura
tive to toxic action but we obtain the impression that these
workers were perhaps prejudiced against the group because �f
a neurotropic tendency which a number of these substances
displayed. This exhibited itself in the development of incoor
dina,tion in the so-called '' dancing-mice.''
Considerations of a practical character have arisen in connec
tion with the arseno compounds caused by certain inherent
difficulties which are associated with their chemic-al and physical
properties. They are unsaturated, highly reactive substances.
Slight modifications in the method or conditions of preparation
may have a great influence on their general toxic and also thera
peutic behavior. It is not possible to obviate this readily by
the subsequent use of the ordinary methods of pul;'ification such
as recrystallization but very careful control of preparative con-
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ditions is required which can be only empirically ascertained.
It has been necessary, therefore, to maintain a constant biological
control of those substances of the group which are clinieally
employed. Further, the development of this class of substances
is in a sense limited because the arseno compounds depend for
solubility on the presence of salt-forming 1 groups. The pentava
lent compounds possess much more favorable chemical and physi
cal properti�. The arsonic acids as a rule are perfectly stable,
crystalline compounds which can be readily purified. They
form· stable salts and therefore do not require the presence of
other salt-forming groups for solubility.
It appeared to us, therefore, that the development of penta
valent compounds was certainly worthy of further trial. In
the selection of the chemical material for our studies such groups
of substances were chosen �hich would combine a sufficient
degroo of accessibility with the opportunity for ample and logical
chemical development in such direction as the biological result
might indicate. From this material .it was hoped to accumulate
statistical data regarding the influence of chemical constitution
on biological act'ion which could be utilized in further work.
An idea of the chemistry. of these groups of substances is best
obtained by reference to the chart. 82 The studies were not alone
confined to the pentavalent group but in certain instances where
the presence _of a solubilizing group would permit, reduction to
the trivalent stage was tried to test the value of such a chemical
transformation.
Over 230 substances were prepared. Their action as regards
toxicity and therapeutic properties in one or more laboratory
animals infected with the different animal parasites was studied.
The observations were too extensive to attempt t._o do .more here
than very briefly and superficially summarize the results. Sub
stances were observed which varied all the way from those posses
sing a very high toxic.ity to such which were easily tolerated
and at the same time exhibited varying degrees of therapeutic
power. But the observations with these substances brought out
the fact that in the biological measure of each compound so
many different factors had to be considered that it became ex-
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tremely difficult to find any sharp·regularities with regard to the
influence of structure on action. But in some cases, it was possi
ble to note a. few very general tendencies which were utilized
.,
to advantage in the work.
The most important group and that which was most fully
studied was that of the amide and substituted amides of phenyl
glycine-p,-arsoni:c acid:. This type of compound was chosen
partly for the reason that the ·glycine amide NHCH2CONH group
not only offered an excellent chance to add practically any chemi
cal group to the molecule which was desired, but because the
glycine amide group itself is a norm•al constituent of proteins and
should be inherently compatible. These substances were in gen
eral prepared by the interaction of the amino group in arsanilic
acid or its analogues with chloroacetyl derivatives of amines in
which members of both the aliphatic and aromatic series were
· given ample representation. Changes in both therapeutic and
toxic effects were observed in response to chemical alterations
in the molecule often of a decided character which depended
not only upon the animal used but also the type of infecting
0rganism. Only in certain instances was it possible to fol
low any general tendencies. To begin with, the parent sub
stance, phenylglycine-p-arsonic Mid, we have met a near relative
before in the form of arsenophenylglycine, which is obtained
from the arsonic acid by reduction. Contrary, however, to
the potent therapeutic properties exhibited by arsenophenyl
glycine in experimental trypanosomiasis, the pentavalent form,
while it can be tolerated by laboratory animals in large amounts,
is practically devoid of therapeutic effect. In this series, as
far as it was carried, the ca'rboxyl group, while acting fairly
constantly as a detoxifying influence, was found to possess a
dystherapeutic effect. This was at variance with instances
noted in other groups of compounds and like all such irregu
larities, which have made prediction impossible, there is no
explanation at hand. · In general, it has become evident that
the tendencies which are observed in the apparent influence
of constitution on biological action are confined pretty nar
rowly to substances which are built on the same general pla.n.
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On passing to the amide or ureides of the compounds contain
ing these carboxyl groups, no matter where they were situated
in the molecule, there was in general an appearance iof thera�
peutic effect in spite of a tendency to increased toxicity. This
therapeutic effect of course varied greatly with the particular
compound, the animal and the infection used. A number of
substances of the series from the biological standpoint proved
to be of outstanding interest. In an extensive series of biological
tests, Doctors Brown and Pearce 83 definitely established that
one of these in particular possesses unusually favorable biologi
cal properties. This substance, the sodium salt of phenylgly
einamide-p-arsonic acid, or tryparsamide, as it has since been
named, has now come to be of definite, practical, therapeutic
importance.
T ryparsamide is a white, crystalline, stable substance which
is extremely soluble in water with the formation of a practically
neutral solution and is very easily prepared by the interaction
of sodium arsanilate and chloroacetamide. As regards the bio
logical properties of this substance, I cannot do better than
quote from Doctor Pearce a sort of summary : 34
'' Toxicological experiments demonstrated that the reaction
of different species of laboratory animals to the drug was of
n favorable character. The substance lends itself well to almost
any method of administration and can be given to animals in
large doses and the toxic effects were confined to doses relatively
close to the minimum lethal dose. The recovery of animals from
sublethal intoxication was remarkably rapid and complete, thus
making possible the repetition of large doses at comparatively
short intervals of time. The therapeutic activity of the drug
in experimental trypanosomiasis was particularly evidenced by
the relative speed and sharpness of action in the acute blood
infections of mice and rats and by the potency and duration of
action in the subacute and chronic tissue infections of guinea
pigs and rabbits. The accomplishment of a permanent cure was
obtained in the experimental infections proauced by five strains
of pathogenic trypanosomes. Tr. brucei, Tr. gambiense, Tr.
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evansi, Tr. equiperdum and Tr. equinum. Comparative experi
ments in laboratory animals with drugs which had been previously
used, such as atoxyl, arsacetin, arsenophenylglycine, and the sal
varsan derivatives, all of which had been previously used in the
treatment of human trypanosomiasis, showed that tryparsamide
was in many respects superior.''
In her clinical observations made in the Belgian Congo several
years ago, Doctor Pe.arce,8' was able to substantiate the favorable
indications which the experimental results with tryparsamide
had given. It was shown that the drug was well tolerated and
gives rise to no untoward symlptoms except an occasional ten
dency, following too intensive a use of the drug, to produce
visual disturbance in certain advanced cases. This, however,
was usually transitory. The therapeutic results obtained in the
preliminary use of the drug in 77 cases of sleeping sickness pro
duced by Trypanosoma gambiense were very encouraging. More
recently, Doctor Chesterman 35 in the Belgian Congo has defi
nitely confirmed Doctor Pearce's general observations. From
observations on the intravenous use of the drug he concludes
that the maximum tolerated dose (which he believes should not
exceed 4 grams per week for the full-sized adult) if given
regularly for a period of about eight weeks is capable of com
pletely removing trypanosomes from and rendering normal, the
cell content of the cerebrospinal fluid of even the most advanced
cases. This change is accompanied by a very marked clinical
improvement which was observed to persist for practically a
year, which was the longest time which had elapsed since his
last use of the drug. Improvement was 'hardly less marked
in cases which had resisted previous treatment with the drugs
such as atoxyl. By a careful check on the patient it was possi
ble to avoid the danger of any aP.Preciable degree of visual
disturbance. Up to the present, we see no reason to change our
estimates of the value of the drug.
Doctor Smillie 80 has recently had the opportunity to extend
the studies with tryparsamide in another direction, to the treat
ment of mal de cad.eras which has become one of the biggest eco-
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nomic. problems of the vast Paraguay Valley in South America,
since this disease is causing the yearly loss of thousands of
horses. In a preliminary communication he reports that the
drug has been found to be definitely efficacious in the treat
ment of the early stages of the disease when the blood of the
horse or mule is swarming with trypanosomes. This stage is
from all practical considerations of the greatest importance
to control.
But to return to human trypanosomiasis, it is seen that the
two main directions which chemical
efforts have taken to pro·,
duce remedies for this disease have almost simultaneously yielded
results which now give a more encouraging outlook with regard
to its control-on the one hand, Bayer-205, most probably closely
related to the benzidine dye group, and tryparsamide, a penta
valent arsenic compound. At the present time, it is perhaps
too early to compare the relative efficacy of Bayer-205 and trypar
sam.ide. There have been reports already with regard to Bayer205 which indicate that the drug, although of definite value as
a prophylactic, or i.in the early stages of the disease, has failed
to give results in the more advanced cases. Tryparsamide, ou the
other hand, as Pearce and Chesterman have shown, has been
the cause of definite improvement in patients even in the more
advanced stages of the disease. Bayer-205 has been reported
to exhibit a definite toxic behavior from which the patients
or animals only slowly recover. This takes the form occasiop
ally of an albuminuria. A general tonic effect has characterfa.zed
the behavior of tryparsamide and perhaps the only untoward
action has been the occasional visual disturbance which has
been noted to follow., too intensive a use of the drug. But, as
before stated, this is in most cases of a temporary character.
We shall perhaps have to wait a number of years before these
drugs will have reached their final evaluation.
There is a temptation perhaps to speculate with regard to
the chance that the more successful of the arseniool remedies
which have been used for the treatment of human trypano
somiasis have been pentavalent compounds. In the case of
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trypari:,amide, there seems every reason to attribute itc;; efficacy,
not only to its powerful stimulating action on the animal economy
and on the animal resistance, but to its great tissue penetrability
and to its affinity for the tissues of the central nervous system
which are involved in the more advanced stages of the human
disease. This property has been demonstrated again in the
behavior of the drug in certain types of neurosyphilis. In neuro
syphilis ther� is a distribution of organisms in the central nervous
system which is1 in a sense, comparable to that which occurs in
trypanosomiasis. This has in the past suggested the possibility
that perhaps even at the time when the etiological relationship of
paresis to syphilis was merely suspected, drugs which have proved
efficacious in the treatment of human trypanosomiasis might find
a usefulness in the treatment of paresis. Years ago, atoxyl, for
instance, was repeatedly tried in this connection, but in all
these attempts, it has proved quite inadequate. It was, however,
a natural thought to consider tryparsamide in this connection,
although its treponemacidal properties are not very marked.
Nevertheless, in experiments in rabbits . it had been shown to
possess a marked action on the experimental lesions produced by
the spirochetes. This was evidenced by their complete resolution
and healing even in the presence of actively motile spirochetes
which seemed to show little or no tendency to cause a recurrence.
A few years ago, Doctors Lorenz, :Jjoevenhart, Bleckwenn,
and Hodges,37 in order to test the applicability of tryparsamide
in this connection undertook a series of observations on a group
of patients afflicted with paresis. They have concluded that
tryparsamide on intravenous injection is definitely efficacious
in the treatment of early paresis and certain other forms of neuro
syphilis. Later observations have essentially confirmed this.
It is perhaps too early to make a more precise statement with
regard to the clinical use in all , of its phases of tryparsamide
in this disease, but sufficient is already known to demonstrate
that it should have a field of usefulness in �ertain conditions
for which there has been, heretofore, no efficacious mode of
treatment.
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If time would permit, still other phases of the progress which
bas been made in the application of chemical agents to the
specific treatment of infectious diseases might be reviewed. But
sufficient has been brought before you tonight to show .that the
results achieved have been far in excess of what was needed
to justify the initiation of this type of investigation. In no
sense, however, can any result such as the arsphenamines, Bayer205 or tryparsamide be considered the sU.IIlllilit of possible attain
ment and there is every reason to expect the ultimate discovery
of more powerful agents. And as time goes on, new groups
of substances and an ever-widening field for their therapeutic
application may well be expected. There is perhaps no more
hopeful direction for the continuation of effort. But those who
engage in such undertaking must carry with them a certain
measure of opportunism., since in spite of the constantly in
creasing number of positive observations, there is still lacking
a general theory as to the chemical and physical factors which
underlie specific therapeutic action. In this respect we are
perhaps less informed than in the case of certain rules which
seem to govern pharmacodynamic action. But I think that it is
in this direction that further effort is required. We should not
alone strive for the attainment of practical results, but continued
attempts should be made to ascertain all of the theoretical factors
which may contribute to chemotherapeutic action.
BIBLIOGRAPHY
'Koch, R.: Mitt. a. d. Kais. Gesundheitsamt., Bd. i, 234 (1881).
• Citation from Morgenroth, J., Therap. Monatshefte, xx:vi, 97 (1912).
1
Bechhold and Ehrlich, P.: Zeitschr. f. physiol. Chem., xlvii, 173 (1906).
Bechhold: Zeitschr. f. physiol. Chem., Iii, 177 ( 1907).
Bechhold: Zeitschr. f. Hygiene, lxiv, 113 (1909).
'Jacobs, W. A.: Jour. Exp. Med., xxiii, 563 (1916).
Jacobs, W. A., Heidelberger, M., and A.moss, H. L.: Jour. Exp. Med.,
xxiii, 569 (1916).
Jacobs, W. A., Heidelberger, M., and Bull, C. G.: Jour. Exp. Med., xxiii,
577 (1916).
1 Browning:, C. H., Cohen, and Gulbransen, R.: Brit. Med. Jour., i, 514
(1922).

94

HARVEY SOCIETY

• Felton, L., and Dougherty, K.: Jour. Exp. Med., xxxv, 761 (1922) and
unpublished observations.
• Browning, C. H., Gulbransen, R., Kennaway. E. L., and Thornton, L. H.
D.: Brit. Med. Jour., i, 73 (1917).
• Felton, L. D., and Dougherty, K. M.: Jour. Exp. Med., xxxvi, 163 ( 1922)
and unpublished observations ..
"Moore, H. F., and Chesney, A. M.: Arch. Int. Med., xix, 611 (1917);
xxi, 659 (1918).
10
Browning, C. H., and Gulbransen, R.: Proc. Roy, Soc. B. xc, 136 (1917).
11
Neufeld, F.: Zeitschr. f. Hyg., xxxiv, 454 (1900).
Schilling: Centr. f. Bakter., Orig. xx.xi, 452 (1902).
Neufeld, F., and v. Prowazek: Arbeit, a. d. Kais. Gesundheitsamt, xxv,
494 (1907).
18
Morgenroth, J., and Halberstiidter, L.: Berl. klin. Wochenschr., xlvii, 646
( 1910) ; xlviii, 558 (1911).
"'Morgenroth, J., and Levy, R.: Berl. klin. Wochenschr., xlviii, 1560, 1979
(1911).
u Wright, A.: Lancet, ii, 1633, 1701 ( 1912).
11
Morgenroth, J., and Tugenreich, J.: Berl. klin. Wochenschr., liii, 794
(1916).
Morgenroth, J., and Tugenreich, J.: Biochem. Zeitschr., Ix.xix, 257 (1917).
1'Neufeld, F., and Engwer: Berl. klin. Wochenschr., xlix, 2381 (1912).
1• Moore, It. F.: Jour. Exp. Med., xxii, 269, 389 (1915).
• Jacobs, W. A., and Heidelberger, M.: Jour. Am. Chem. Soc., xii, 2090
(1919).
10
Jacobs, W. A., and Heidelberger, M.: Jour. Am. Chem. Soc., xli, 2131
(1919).
"Jacobs, W. A., and Heidelberger, M.: Jour. Am. Chem. Soc., xli, 817;
xlii, 1481, 1480, 2278; xliv, 1073, 1079, 1091, 1098.
11 Laveran, A., and Mesnil, F.: Ann: d l'Inst. Pasteur, xvi, l (1902).
"Ehrlich, P., and Shiga: Berl. klin. Wochenschr., xli, 329, 362 (1904).
11
Mesnil, F., and Nicolle, M.: Ann.. d. l'Inst. Pasteur,'xx, 417, 513 (1906).
"Dale, H. H.: Physiol. Reviews, iii, 369 (1923).
11 Handel and Joetten: Berl. klin .. Wochenschr., lvii, 821 (1920).
"Mayer and Zeiss: Arch. f. Schiffs. u. Tropen-Hyg., xxiv, 257 (1920).
11 Thomas, H. W.: Brit. Med. Jour., i, 1140 (1905).
18
Ehrlich, P., and Bertheim, A.: Ber. d. deut. chem. Gesell., xl, 3292
(1907)
.. Ehrlich, P.: Ber. d. deut. chem. Geseil., xiii, 17 (190,9).
•• Ehrlich-Hata: Die Exper. Chemotherapie d. Spirillosen., Berlin (1910).
11
Riihl, W.: Zeit. f. Immunitiitsforsch., ii, 1, 496 (1909).
Berl. klin. Wochenschr., xlvi, 494 ( 1909).

PROTOZOAN AND BACTERIAL INFECTIONS

95

Jacobs, W. A., and Heidelberger, M.: Jour. .Am. Chem. Soc., xli, 1581,
1587, 1600, 1610, 1809, 1822, 1826, 1834 (191.9); xliii, 1632, Hl46
(1921).
•Jacobs, W. A., and Heidelberger, M.: Jour. Exp. Med., xxx, 411 (1Sll9).
Brown, W. H., and Pearce, L.: Jour. Exp. Med., xxx, 417-96 (1919).
"Pearce, L.: Jour. Exp. Med., xxxiv, Supplement No. 1 ( 1921).
• Chesterman, C. C.: Trans Roy, Soc. Trop. Med. and Hyg., xvi, 394
(1923).
• Smillie, W. G.: Jour. Am. Vet. M. A., September, 1923.
nLoren.z, W. F., Loevenhart, A. S., Bleckwenn, W. J., and Hodges, F. J.:
Jour. Am. Med. Assn., 80, 1497 ( 1923).

11

